NRx Pharmaceuticals (NASDAQ:NRXP) Research Coverage Started at BTIG Research
BTIG Research assumed coverage on shares of NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) in a research report released on Wednesday morning, MarketBeat reports. The brokerage issued a buy rating ...
Le Lézard2d
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
Meitheal Pharmaceuticals, Inc. ("Meitheal"), a fully integrated biopharmaceutical company based in Chicago focused on the development and commercialization of generic injectables, fertility, biologic, ...
Le Lézard2d
Cadwell Unveils Synchronized EMG and Ultrasound, Q-Mode and Other Innovations in Latest Sierra Software Release
Cadwell Industries, Inc., a global leader in neurodiagnostic, neuromonitoring and sleep solutions, launched its latest Sierratm software release providing patent-pending, fully-synchronized ...
Fintel on MSN2d
BTIG Initiates Coverage of NRx Pharmaceuticals (NRXP) with Buy Recommendation
Fintel reports that on April 2, 2025, BTIG initiated coverage of NRx Pharmaceuticals (NasdaqCM:NRXP) with a Buy ...
NRx Pharmaceuticals initiated with a Buy at BTIG
BTIG initiated coverage of NRx Pharmaceuticals (NRXP) with a Buy rating and $18 price target NRx Pharmaceuticals is working broadly in ...
Green Market Report4d
HOPE Therapeutics to buy clinic company Dura Medical
Durand is a U.S. Army Reserve veteran, and Dura Medical provides for the Veterans Affairs Community Cares Network (VA CCN) ...
NRx Pharmaceuticals’ Hope Therapeutics to acquire Dura Medical, no terms
Hope Therapeutics, an interventional psychiatry network wholly owned by NRx Pharmaceuticals (NRXP), announced signing of a definitive agreement ...
Taiwan News10d
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
An inflection in prescription demand first observed in September 2024 NRx continued in fourth quarter 2024 and extended to TRx. NRx increased 12% from approximately 25,600 in third quarter 2024 to ...
NRx Pharmaceuticals (NRXP) Expected to Announce Earnings on Wednesday
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) will likely be releasing its earnings data after the market closes on ...
Investing15d
NRX Pharmaceuticals Inc (NRXP)
Investing.com - NRX Pharmaceuticals (NASDAQ: NRXP) reported second quarter EPS of $-0.120, $0.01 better than the analyst estimate... ByInvesting.com • Aug 14, 2023 NRx Pharmaceuticals signs U.S ...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and Full Year 2024 Earnings Call. At this time, all lines are in ...
ProPublica16d
The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems.
The agency inspected the factory after a ProPublica investigation in December found that the plant, operated by Glenmark Pharmaceuticals, was responsible for an outsized share of recalls for pills ...